Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

M2-mAChRs as therapeutic targets for treating substance use disorders

July 28, 2022

Clearmind reports safety and reduced alcohol consumption with combination of MEAI and CannAmide

May 25, 2022

Clearmind's MEAI shows suppressive effect on alcohol consumption in mice

May 20, 2022

Novel selective D3R ligands for the treatment of drug addiction

May 19, 2022

M1 mAChR antagonism attenuates opioid drug seeking behaviors in rat

May 5, 2022

CNRS and collaborators patent acetylcholinesterase reactivators

April 1, 2022

Red Bull GmbH presents dopamine reuptake inhibitors

Jan. 20, 2022

Metabotropic glutamate mGlu2 receptor found to be associated with alcoholism

Nov. 30, 2021

Researchers develop a rat model of oxycodone/cocaine withdrawal syndrome

Nov. 23, 2021

One-year challenge data from preclinical study of ATI-1701 in lethal model of tularemia

Nov. 22, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...